Literature DB >> 11318756

Efficacy of nonwoven fabric bioreactor immobilized with porcine hepatocytes for ex vivo xenogeneic perfusion treatment of liver failure in dogs.

K Naruse1, Y Sakai, G Lei, Y Sakamoto, T Kobayashi, C Puliatti, G Aronica, W Morale, F Leone, S Qiang, S G Ming, S Ming, Z Li, S J Chang, M Suzuki, M Makuuchi.   

Abstract

We have developed a new bioartificial liver bioreactor filled with porcine hepatocytes immobilized on polyester nonwoven fabric (NWF). In this study, we investigated the efficacy of our hybrid bioartificial liver system incorporating the NWF bioreactors and an immunoglobulin adsorbent column for perfusion treatment in a canine liver failure model. Xenogeneic perfusion treatment for operative canine liver failure models were performed for 3 h, and survival time, intracranial pressure, and blood and cerebrospinal fluid data were documented. Treatment was carried out without obstruction by immunological rejection when immunoglobulin adsorbent columns were used with the NWF bioreactors in combination. Dogs treated with this system exhibited a restricted increase of intracranial pressure and significant compensatory effects on blood and cerebrospinal amino acid imbalances as shown by a significant improvement of Fischer's ratio. On the other hand, relatively low capacity for ammonia elimination was shown as compared with homologous direct hemoperfusion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318756

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  2 in total

Review 1.  Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.

Authors:  Katsutoshi Naruse; Wei Tang; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

2.  Functional evaluation of a new bioartificial liver system in vitro and in vitro.

Authors:  Zhong Chen; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.